1 Leclerc S, Myers RP, Moussalli J, Herson S, Poynard T, Benveniste O.Sarcoidosis and interferon therapy:report of five cases and review of the literature[J].Eur J Intern Med, 2003;14 (4):237-43
2 Keating A.Chronic myeloid leukemia:current therapies and the potential role of farnesyl transferase inhibitors[J].Semin Hematol, 2002;39(3):11-7
3 Blankenstein T, Qin Z.The role of IFN-gamma in tumor transplantation immunity and inhibition of chemical carcinogenesis [J].Curr Opin Immunol, 2003;15(2):148-54
4 Chawla-Sarkar M, Lindner DJ, Liu YF, Williams BR, Sen GC, Silverman RH, et al.Apoptosis and interferons:role of interferon-stimulated genes as mediators of apoptosis[J].Apoptosis, 2003;8(3):237-49
5 Chada S, Ramesh R, Mhashilkar AM.Cytokine-and chemokine-based gene therapy for cancer[J].Curr Opin Mol Ther, 2003;5(5):463-74
6 Lehtonen A, Lund R, Lahesmaa R, Julkunen I, Sareneva T, Matikainen S.IFN-alpha and IL-12 activate IFN regulatory factor 1 (IRF-1), IRF-4, and IRF-8 gene expression in human NK and T cells[J].Cytokine, 2003 Nov 7;24(3):81-90
7 Minami R, Muta K, Ilseung C, Abe Y, Nishimura J, Nawata H.Interleukin-6 sensitizes multiple myeloma cell lines for apoptosis induced by interferon-a[J].Exp Hematol, 2000;28(3): 244-7
8 Keating A.Chronic myeloid leukemia:current therapies and the potential role of farnesyl transferase inhibitors[J].Semin Hematol, 2002;39:11-7
9 Mokbel K.The evolving role of telomerase inhibitors in the treatment of cancer[J].Curr Med Res Opin, 2003;19(6):470-2
10 Ohyashiki JH, Sashida G, Tauchi T, Ohyashiki K.Telomeres and telomerase in hematologic neoplasia[J].Oncogene, 2002; 21(4):680-7
11 Nakajima A, Tauchi T, Sashida G, Sumi M, Abe K, Yamamoto K, et al.Telomerase inhibition enhances apoptosis in human acute leukemia cells:possibility of antitelomerase therapy[J].Leukemia, 2003;17(3):560-7 |
